Browse Articles

Discover research articles across all indexed journals

Pachymic acid alleviates circadian rhythm disorders in high-fat diet-induced obesity mice via the sphingolipid pathway

PLoS ONE Hong Yang, Yingxiu Mei, Jilan Chen et al. Jul 01, 2026 DOI: 10.1371/journal.pone.0352604

Background Obesity caused by a high-fat diet (HFD) is known to disrupt metabolic homeostasis and circadian rhythms. Pachymic acid (PA), a bioactive triterpenoid, exhibits anti-inflammatory, antihyperglycemic, antihyperlipidemic, and sedative-hypnotic properties, though its role in circadian regulation remains unexplored. Methods We assessed PA’s impact on metabolic dysfunction (glucose/lipid profiles), systemic inflammation using biochemical assays, ELISA, Oil Red O staining. Circadian parameters were evaluated via 24-h serum melatonin and core body temperature. Hepatic circadian gene oscillations and mechanistic pathways were analyzed through time-series RNA sequencing, bioinformatics, qPCR, and Western blotting. Results PA intervention attenuated obesity-related phenotypes, including reduced body weight, improved glucose/lipid metabolism, and restored physiological rhythms of melatonin and body temperature. And hepatic gene oscillation patterns were realigned to circadian synchrony. Mechanistically, PA ameliorated liver inflammation by modulating the sphingolipid pathway, specifically via S1PR4/TRAF2 signaling. Conclusions Our findings illustrate PA’s role in mitigating metabolic and circadian disruptions in obesity, highlighting the sphingolipid pathway as a tissue-specific target for circadian modulation. This study provides novel insights into therapeutic strategies for obesity-associated circadian disorders.

Nanotrap Architectures for Mitigating Interfacial Transport Limitations in Cathode Catalyst Layers of Proton Exchange Membrane Fuel Cells

Advanced Materials Zhiyin Huang, Yuqin Peng, Zhiguo Qu et al. Jul 01, 2026 DOI: 10.1002/adma.73702

ABSTRACT Efficient gas transport and abundant triple‐phase boundaries (TPBs) are vital for thick cathode catalyst layers (CCLs) in proton exchange membrane fuel cells (PEMFCs), yet remain challenging to realize. In this work, we introduce a carbon‐based nanotrap architecture functionalized with pyrrolic‐N groups, which reorganizes the Pt–carbon–ionomer interface to enhance local oxygen supply. These nanotraps simultaneously confine Pt nanoparticles and ionomer, forming continuous pathways for oxygen, protons, and electrons, thereby significantly increasing active TPB density. The underlying enhancement mechanism is validated by x‐ray tomography and 3D two‐phase flow simulations. Using a 15.5 µm‐thick CCL, the optimized electrode achieves peak power densities of 1940 mW cm −2 in H 2 /O 2 and 1410 mW cm −2 in H 2 /Air—improvements of ∼30% and ∼80%, respectively. Moreover, it exhibits a good stability, with a voltage decay rate of only 43.8 µV h −1 at 1.5 A cm −2 over 1000 h. This nanotrap concept offers a versatile interfacial design strategy for advanced gas‐diffusion electrodes in energy conversion technologies.

IGSF3 drives acquired temozolomide resistance in glioblastoma through ASNS-dependent asparagine biosynthesis

Journal of Biological Chemistry Jie Li, Hongnian Lu, Qianqian Xu et al. Jul 01, 2026 DOI: 10.1016/j.jbc.2026.113359

Fruquintinib versus trifluridine-tipiracil plus bevacizumab versus regorafenib in refractory metastatic colorectal cancer: A propensity score–matched real-world analysis.

Journal of Clinical Oncology Shankar Biswas, Yashasvi Srivastava, Rahul Falodia et al. Jul 01, 2026 DOI: 10.1200/jco.2026.44.19_suppl.134

134 Background: Fruquintinib, trifluridine-tipiracil plus bevacizumab (FTD/TPI+bev), and regorafenib are approved for refractory metastatic colorectal cancer (mCRC), yet no head-to-head trials compare all three. Real-world data directly comparing these regimens—particularly since all three became simultaneously available after fruquintinib's FDA approval (November 2023)—are lacking. Methods: Using the TriNetX Global Collaborative Network (170 healthcare organizations), adults with mCRC (ICD-10 C18–C20 plus C78–C79) initiating fruquintinib, FTD/TPI+bev (bevacizumab within 30 days of FTD/TPI), or regorafenib were identified. Three pairwise 1:1 propensity score–matched (PSM) analyses adjusted for demographics, Charlson comorbidities, metastatic burden, and baseline labs (albumin, creatinine, hemoglobin, platelets, ALP, LDH, CEA). The primary outcome was overall survival (OS; Kaplan-Meier with log-rank test). Secondary outcomes included adverse events and healthcare utilization (ED visits, hospitalizations). Results: Before PSM, 648 fruquintinib, 2,302 FTD/TPI+bev, and 5,944 regorafenib patients were identified. After matching, all covariates were well balanced (SMD <0.1). FTD/TPI+bev demonstrated significantly longer OS than both fruquintinib (median 11.7 vs 9.9 mo; HR 1.36, 95% CI 1.09–1.68, P=0.005; n=431 pairs) and regorafenib (median 11.8 vs 9.2 mo; HR 1.26, 95% CI 1.13–1.40, P<0.001; n=1,247 pairs). Fruquintinib and regorafenib showed comparable OS (median 8.9 vs 8.6 mo; HR 0.98, 95% CI 0.80–1.20, P=0.81; n=413 pairs). FTD/TPI+bev had significantly higher neutropenia (15.6% vs 5.3%, P<0.001) and thrombocytopenia (9.6% vs 5.7%, P=0.001) versus regorafenib. Hypertension trended higher with fruquintinib versus regorafenib (14.8% vs 9.3%, P=0.12); hand-foot syndrome trended higher with regorafenib versus fruquintinib (6.6% vs 3.8%, P=0.10). No significant differences in hepatotoxicity, diarrhea, GI bleeding, ED visits, or hospitalizations were observed across comparisons. Conclusions: In this real-world analysis, FTD/TPI+bev was associated with significantly superior OS versus both fruquintinib and regorafenib in refractory mCRC, with a 2–3 month median survival advantage. This benefit was accompanied by higher myelosuppression. Fruquintinib and regorafenib showed comparable efficacy with distinct toxicity profiles. These findings support FTD/TPI+bev as a preferred option and highlight the need for individualized treatment selection balancing efficacy and tolerability.

Anion-Directed Assembly of Atomically Precise Silver Nanofibers: Tunable Inner Diameters and Mechanical Exfoliation into Subnanometer Nanofibers

Journal of the American Chemical Society Rakesh Kumar Gupta, Yan Chen, Zhi Wang et al. Jul 01, 2026 DOI: 10.1021/jacs.5c14368

Effects of OsNRT2.3b transgenosis on lettuce antioxidant capacity and nitrogen metabolism under low nitrogen

PLoS ONE Yuxuan Qian, Xue Liu, Baoju Wang et al. Jul 01, 2026 DOI: 10.1371/journal.pone.0352238

Nitrate (NO 3 - ) plays dual roles in vascular plants, functioning as both an essential macronutrient and a phytoactive signaling compound. Research indicates that the high-affinity NO 3 - transporter OsNRT2.3b orchestrates fundamental agronomic traits, including biomass accumulation, grain production, and nitrogen (N) metabolism efficiency in cultivated rice. In this study, transgenic lettuce lines of OsNRT2.3b were generated, from which four lines with high OsNRT2.3b expression (OE20−5, OE21−7, OE21−11, and OE21−13) were selected and subjected to normal (CK) and low nitrogen (LN) treatments for 12 d. The results indicate that OsNRT2.3b transgenosis increased chlorophyll and glutathione (GSH) contents, as well as the activities of superoxide dismutase (SOD), peroxidase (POD), and catalase (CAT), in lettuce. However, OsNRT2.3b transgenosis had little effect on certain agronomic traits (leaf number, plant height, and leaf dimensions) of lettuce. Compared to the wild-type (WT), OsNRT2.3b transgenosis substantially enhanced the contents of NO 3 - , ammonium (NH 4 + ), amino acids, soluble protein, and the activities of NO 3 - reductase (NR), nitrite (NO 2 - ) reductase (NiR), glutamine synthetase (GS), and glutamate synthetase (GOGAT) in lettuce. Thus, OsNRT2.3b transgenosis improves the antioxidant capacity, photosynthetic level, and N use efficiency of lettuce. This research provides theoretical references for improving the N utilization efficiency of lettuce and enhancing its antioxidant capacity.

A Matter of Parameters: Tailored Transcranial Focused Ultrasound Enhances Cortico-Thalamo-Cortical Circuit Resonance

Journal of Neuroscience Ugur Kilic, Justin R. Carter Jul 01, 2026 DOI: 10.1523/jneurosci.1871-25.2026

Lattice‐Engineered Dual‐Electron‐Drive Electrode for Selective Ammonia Production From Nitrate

Advanced Materials Du Chen, Zhongyuan Guo, Jiajie Wang et al. Jul 01, 2026 DOI: 10.1002/adma.73699

ABSTRACT Ammonia (NH 3 ) is indispensable in agriculture and emerging energy systems, yet its conventional production remains energy‐ and carbon‐intensive. Electrochemical nitrate reduction reaction (NO 3 − RR) represents a promising alternative for sustainable NH 3 synthesis but is hampered by slow kinetics and low selectivity under realistic, neutral conditions. Here, we employ the lattice engineering strategy to construct a cobalt‐doped nanoscale zerovalent iron (Co‐nFe 0 ) electrode that integrates a dual‐electron‐drive mechanism with a self‐triggered alkaline microenvironment to overcome these challenges. Cobalt doping modulated the surface Fe electronic structure to create electron‐deficient Fe sites, which enhanced charge transfer, promoted water dissociation into active hydrogen species, and facilitated the hydrogenation of reaction intermediates. This design enabled an NH 3 Faradaic efficiency of 96% and near‐quantitative selectivity across a wide nitrate concentration range (100–1000 mg L −1 NO 3 − ‐N), alongside sustained operational stability. An insitu NH 3 recovery system could provide stable operation over 360 h and deliver 13 g day −1 NH 3 production with 100% NH 3 recovery. Rice pot experiments demonstrated that the recovered ammonium sulfate (99% purity) performed comparably to commercial fertilizers. This work provides an efficient electrocatalyst that couples electronic structure modulation and interfacial microenvironment regulation, thereby offering a sustainable technological route for nitrogen upcycling and green fertilizer production.

Histone Acetyltransferase HAT1 Regulates Intestinal Stem Cell Proliferation and Differentiation

Journal of Biological Chemistry Prabakaran Nagarajan, Caden J. Martin, Andrea R. Keller et al. Jul 01, 2026 DOI: 10.1016/j.jbc.2026.113368

Identification of independent prognostic factors in relapsed pediatric B-ALL patients receiving CD19 CAR-T without consolidative HSCT.

Journal of Clinical Oncology Ning Wang, Lipeng Liu, Junxia Wang et al. Jul 01, 2026 DOI: 10.1200/jco.2026.44.19_suppl.249

249 Background: After CD19 chimeric antigen receptor (CAR) T-cell therapy (CAR-T), some B cell acute lymphoblastic leukemia (B-ALL) patients do not proceed to consolidative hematopoietic stem cell transplantation (HSCT) for various reasons. However, the specific characteristics of patients who can achieve long-term survival without subsequent HSCT remain to be elucidated. This study aimed to identify independent predictors of Relapse-Free Survival (RFS) in patients who achieved complete remission after CD19 CAR-T but did not undergo subsequent HSCT. Methods: We conducted a single-center retrospective study in a cohort of relapsed pediatric B-ALL patients (n=52) receiving CD19 CAR-T without consolidative HSCT. Candidate variables were first screened using the Least Absolute Shrinkage and Selection Operator (Lasso) regression. Selected variables were then analyzed in a multivariable penalized Firth Cox proportional hazards model to address the issues of small sample size and complete separation. Results: The median follow-up was 39 months. The 3-year RFS was 40.9% (95% CI: 28.5-58.6%). The Lasso regression selected four variables including B-cell aplasia (BCA) duration after infusion, minimal residual disease (MRD) level before infusion, time to initial relapse and relapse site for the final model. The subsequent stratified Firth Cox model was highly significant (Likelihood Ratio Test p = 8.1e-07). BCA duration (≥ 6 months vs. < 6 months) was a strong independent protective factor (Hazard Ratio, HR = 0.032; 95% CI: 0.00025 - 0.230; p < 0.001). Relapse site (bone marrow relapse vs. isolated extramedullary relapse) was a significant independent risk factor (HR = 3.47; 95% CI: 1.06 – 11.57; p = 0.039). The effects of MRD and the stratified time to relapse were not statistically significant. Conclusions: Patients with BCA duration ≥ 6 months after CD19 CAR-T infusion and isolated extramedullary relapse have a significantly more favorable prognosis, defining a potential low-risk subgroup. This finding requires validation in studies with comparative treatment arms to assess implications for therapeutic strategy.

Self-Coordinating Electronic Metal–Support Interaction Stabilizes Ultralow-Loading Ir Single Atoms for Durable Acidic Oxygen Evolution

Journal of the American Chemical Society Yilin Gao, Hongqiang Jin, Ruihan Gong et al. Jul 01, 2026 DOI: 10.1021/jacs.6c03983

Intersectional dehumanization in faces: Facial attractiveness and perceived intelligence differentially predict dehumanization across intersecting race and gender identities

PLoS ONE Neelamberi Devi Klein, Kurt Hugenberg Jul 01, 2026 DOI: 10.1371/journal.pone.0351086

Past work has found that more attractive and more intelligent appearing faces are ascribed more humanlike sophistication at zero acquaintance, but past work has only employed White faces. Of interest in the present work is whether similar effects occur across target race. Across two studies we investigate if the relationships between attractiveness and perceived intelligence vary across Black and White, male and female faces. Across both studies, we find that more attractive faces are evaluated as more humanlike across target race and gender, but notably that target race moderates the predictiveness of perceived intelligence. Perceived intelligence only relates to humanness for White targets, but not Black. These findings provide support for the theory that face trait relationships are often dependent on target identities, such as race and are consistent with extended research indicating that Black Americans’ minds may be devalued.

Molecularly Confined Domains Enable Halide‐Stable Wide‐Bandgap Perovskites

Advanced Materials Youming Zhu, Biao Li, Baochao Zheng et al. Jul 01, 2026 DOI: 10.1002/adma.73713

ABSTRACT Stable wide‐bandgap (WBG) perovskites are essential for achieving highly efficient tandem photovoltaics. However, state‐of‐the‐art tandem solar cells typically employ mixed‐halide WBG perovskite, yet halide phase segregation remains a critical bottleneck. Here, we design a molecular confinement domain in which paired iodide‐bearing organic ligands bind adjacent FA + cations and are interconnected by a bifunctional diammonium linker, effectively suppressing halide segregation by constraining the dynamic motion of orientable FA + cations at the surface and interfaces of wide‐bandgap perovskites. The suppression of this motion effectively strengthens lead‐halide (Pb‐X) bond strength, reinforces the lattice rigidity, reduces lattice vibrational amplitude and increases halide ion migration energy barrier. As a result, I‐Br mixed‐halide segregation and defect evolution under prolonged illumination are effectively suppressed. Finally, the resulting mixed‐halide WBG films exhibit low trap densities, improved carrier transport, and enhanced light/thermal stability. Such concept is applicable to both 1.68 and 1.78 eV perovskite, yielding efficiencies of 24.21% and 21.20% in single‐junction cells, respectively. When integrated into silicon‐based tandem cells, the device delivers an efficiency of 33.59%, alongside durable long‐term stability with a T 96 lifetime of 1000 h under continuous operation.

Macrocyclic and linear peptides promote LAR dimerization and neurite outgrowth

Journal of Biological Chemistry Misato Yasumura, YuChen Zhang, Tokuichi Iguchi et al. Jul 01, 2026 DOI: 10.1016/j.jbc.2026.113340

Patient-reported outcomes for effective screening of chemotherapy-induced peripheral neuropathy.

Journal of Clinical Oncology Gowri Shivasabesan, Alice Treloar, Victoria Choi et al. Jul 01, 2026 DOI: 10.1200/jco.2026.44.19_suppl.350

350 Background: Effective toxicity screening is necessary to improve cancer care. Chemotherapy-induced peripheral neuropathy (CIPN) frequently leads to cancer treatment modifications as well as long-term morbidity. However, CIPN screening varies widely between clinics, resulting in discrepancies in care. To optimise CIPN screening for real-world use, it is important to understand the reliability and validity of patient-reported outcome measures (PROMs), and to identify which specific questions may signal CIPN severity in routine practice. Methods: In a prospective study across two Australian sites, patients receiving neurotoxic therapy completed CIPN screening using the Cancer Institute NSW EviQ online neurotoxicity instrument and the validated European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Chemotherapy Induced Peripheral Neuropathy 20-item scale (EORTC-QLQ-CIPN20). Composite scores for CIPN-20 were generated by linearly converting scores. Reliability was assessed using Cronbach’s alpha. Spearman’s correlation was used to analyze item-level correlations with the CIPN20 composite score. Results: One hundred participants (median age: 53 years, 72% female) with predominantly breast (46%) or gastrointestinal (13%) malignancies, received taxane (58%) and/or platinum (33%) chemotherapy. Both screening tools showed good internal consistency (CIPN20 α=0.84; eviQ α=0.81). Only one individual item from EviQ was strongly correlated with CIPN20 composite score – “pain or discomfort in hands or feet” (r = 0.70). Multiple questions on sensory and motor function showed moderate correlation (r = 0.4 – 0.7, Table 1). However, items addressing autonomic function (e.g. constipation, dizziness) or breathing difficulties demonstrated low correlations (r < 0.4). Conclusions: Only a small subset of items showed a moderate-to-strong association with the CIPN20 composite score. It may be possible to use a concise set of PROM items to screen for CIPN severity, supporting better and more efficient clinical decision-making. The strength of correlation between EViQ questions with EORTC QLQ-CIPN20 composite score. EviQ Question Spearman's rho (p-value) 1) Numbness or tingling in hands or feet 0.62 (<0.001) 2) Pain or discomfort in hands or feet 0.70 (<0.001) 3) Weakness in arms or legs 0.49 (<0.001) 4) Problems walking 0.55 (<0.001) 5) Able to undertake activities of daily living independently (doing up buttons, writing etc.) 0.5 (<0.001) 6) Currently constipated 0.09 (0.4) 7) Hearing loss 0.33 (<0.001) 8) Ringing or buzzing in ears 0.20 (0.04) 9) Dizziness 0.26 (0.01) 10) Breathing/swallowing/ eating/drinking difficulties 0.25 (0.01) 11) Muscle spasms in mouth/jaw/hands/fingers/feet/ toes 0.42 (<0.001) Legend:. Grading scale:. EviQ: None (0) --> Disabling/life threatening (4). Strength of association: Strong (r ≥ 0.7) / Moderate (r =0-4 -0.7) / Weak (r < 0.4).

Lattice-Directed Spin-Vibronic Coherence-Mediated Ultrafast Intersystem Crossing in Crystalline Diplatinum Complex

Journal of the American Chemical Society Nita Ghosh, Julien Eng, Sarah Kromer et al. Jul 01, 2026 DOI: 10.1021/jacs.6c04591

The effects of material type, salivary contamination and adhesive application on the performance of pit and fissure sealants

PLoS ONE Adem Gok, Kubra Bilge, Tuba Gok Jul 01, 2026 DOI: 10.1371/journal.pone.0352985

This study aimed to assess the effects of sealant material type, adhesive application and saliva contamination on the microleakage, shear bond strength (SBS), and interfacial adaptation of pit and fissure sealants. A total of 160 extracted human molars were assigned to eight groups according to sealant type (resin-based, glass ionomer-based, or flowable composite), adhesive application, and contamination condition. Microleakage and unfilled areas at the enamel–sealant interface were assessed by dye penetration and image analysis software after thermocycling. SBS was measured using a universal testing machine, and failure modes were categorized under a stereomicroscope. Interfacial adaptation was analyzed using scanning electron microscopy (SEM). Data were analyzed with Fisher’s exact, Kruskal–Wallis, Mann–Whitney U, and ANOVA tests (α = 0.05). Resin-based and flowable composite sealants exhibited significantly lower microleakage and higher SBS than glass ionomer-based materials (p < 0.05). Adhesive application enhanced SBS but slightly increased microleakage. Saliva contamination markedly reduced bond strength and increased leakage, whereas re-etching effectively restored enamel receptivity and sealing ability. SEM images revealed better adaptation and continuous margins in resin-based and flowable composites, whereas contaminated groups exhibited irregular interfaces and micro gaps. Sealant performance is strongly influenced by material viscosity, surface pretreatment, and contamination control. Re-etching after contamination restores enamel-bonding potential, while adhesive-assisted flowable composites achieve the best combination of sealing, retention, and interfacial adaptation, suggesting their clinical advantage in moisture-compromised environments.

A Multifunctional Electrolyte Additive K <sub>3</sub> P <sub>7</sub> for Simultaneous Capacity Compensation and Interphase Regulation in Lithium‐Ion Batteries

Advanced Materials Xiaoyi Wang, Yiqing Li, Zichuan Wang et al. Jul 01, 2026 DOI: 10.1002/adma.73676

ABSTRACT The initial irreversible capacity loss (ICL) during the first charge significantly reduces the energy and power densities of lithium‑ion batteries (LIBs). Conventional prelithiation additives suffer from limited theoretical specific capacities (300–1000 mAh g −1 ), poor air stability, and low conversion efficiency. Herein, K 3 P 7 , which possesses high solubility in ester‐based electrolytes, is introduced as an electrolyte additive to improve the reversible capacities of various commercial LIBs. It provides an exceptional capacity‑compensation effect through the oxidation of P 7 3− , equivalent to 3048 mAh g −1 . Additionally, K + ions intercalate into the graphite interlayer, expanding the interlayer spacing and thereby improving the high‑rate performance of the graphite anode. The additive also promotes the formation of a stable cathode electrolyte interphase (CEI) and a uniform solid electrolyte interface (SEI), contributing to improved cycle stability of both electrodes. Furthermore, K 3 P 7 effectively scavenges free radicals, alleviating gas generation and internal pressure build‑up. When applied in a LiNi 0.8 Co 0.1 Mn 0.1 O 2 ||graphite full cell, the initial reversible capacity is 8% higher than that of the control sample, and the cell retains 92.9% of its capacity after 200 cycles. This work reveals a facile multi‐functional electrolyte additive that enhances the overall performance of LIBs.

Molecular mechanism of 2′,3′-cGAMP degradation by monkeypox virus poxin-schlafen protein

Journal of Biological Chemistry Yunxiao Huang, Benzhen Duan, Yang Xiao et al. Jul 01, 2026 DOI: 10.1016/j.jbc.2026.113163

Shared tumor-reactive T cell clonotypes from tumor-infiltrating lymphocytes and tumor-associated lymph nodes defined by single-cell sequencing and tumor organoid models in non-small cell lung cancer.

Journal of Clinical Oncology Yin Li, Zhenjiang Liu, Ke Liu et al. Jul 01, 2026 DOI: 10.1200/jco.2026.44.19_suppl.275

275 Background: Tumor-infiltrating lymphocytes (TILs) are a critical subset of immune cells in solid tumors, particularly in non-small cell lung cancer (NSCLC), and serve as a cornerstone in cancer immunotherapy. While TILs can be enriched for tumor-specific reactivity, the challenge remains in the precise identification and isolation of the potent tumor-reactive T cells. This study investigates TILs and tumor-associated lymph nodes (TALNs) as alternative sources of tumor-specific T cells and leverages single-cell sequencing to delineate their molecular signatures under stimulation with tumor antigens derived from tumor cells or patient-derived tumor organoids (PDTOs). Methods: TILs, TALN-derived T cells and PDTOs were isolated from paired surgically resected NSCLC tumor tissues to model tumor-immune interactions ex vivo. Functional assays, along with single-cell RNA sequencing were employed to identify and characterize putative tumor-reactive T cells. Additionally, T-cell receptor (TCR) sequencing was utilized to track tumor-reactive TCR clonotypes within three types of T cells. Results: CD137+ TILs from NSCLC tumors harbor a significantly higher proportion of tumor-specific T cells and enhanced activation potency and effector functions than T cells from PBMC. PDTOs closely mimic the primary tumors. TILs activated by PDTOs or autologous tumors have similar TCR clonotypes and tumor-specific expression. T cells derived from TALNs share similar TCR clonotypes with TILs. Conclusions: This study underscores the superior tumor specificity of TILs with CD137 expression and supports the utility of PDTOs as a robust platform for evaluating immune function in NSCLC. Additionally, TALNs demonstrate a distribution pattern that aligns with the tumor's lymphatic drainage and metastatic behavior.